Comparison of lithium, aripiprazole and olanzapine as augmentation to paroxetine for inpatients with major depressive disorder

BACKGROUND: Selective serotonin reuptake inhibitors (SSRIs) are considered first-line treatments for major depressive disorders (MDD). It has been reported, however, that 30–40% of patients with MDD who received SSRIs failed to respond to treatment. Use of lithium (Li) to augment SSRIs seems to be t...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Yoshimura, Reiji, Hori, Hikaru, Umene-Nakano, Wakako, Ikenouchi-Sugita, Atsuko, Katsuki, Asuka, Atake, Kiyokazu, Nakamura, Jun
Format: Artigo
Sprache:Inglês
Veröffentlicht: SAGE Publications 2014
Schlagworte:
Original Research
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC4107705/
https://ncbi.nlm.nih.gov/pubmed/25057345
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/2045125313514767
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge